ClinicalTrials.govpublic full text
Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
non small cell lung carcinoma, nsclc, cox-2-inhibitor, radiosensitizer, radiotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1031133
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.